Phase III study of N, N-Diethyl-2-[4-(Phenylmethyl) Phenoxyl] Ethanamine (BMS-2173801-01) combined with doxorubicin versus doxorubicin alone in metastatic/recurrent breast cancer: National Cancer Institute of Canada Clinical Trials Group Study MA-19

Author：  

Publisher： Informa Healthcare

ISSN： 1473-3404

Source： The Women's Oncology Review, Vol.4, Iss.2, 2004-06, pp. : 133-134

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The intracellular histamine antagonist, N,N-diethyl-2-[4-(phenylmethyl)phenoxy] ethanamine.HCl, may potentiate doxorubicin in the treatment of metastatic breast cancer: Results of a pilot study

By Brandes Lorne   Bracken Susan  

Breast Cancer Research and Treatment, Vol. 49, Iss. 1, 1998-05 ,pp. : 61-68

Springer Publishing Company

Access to resources Recommend Favorite

Combined Effects of Cisplatin and N, N-Diethyl-2-[4-(Phenylmethyl)Phenoxy] Ethanamine HCl on the Growth of Human Ovarian Cancer Xenografts in Nude Mice

By Hiramatsu H.   Kudoh K.   Kikuchi Y.   Hirata J.   Kita T.   Yamamoto K.   Tode T.   Nagata I.  

European Journal of Cancer, Vol. 33, Iss. 11, 1997-10 ,pp. : 1904-1905

Elsevier

Access to resources Recommend Favorite

A randomized crossover trial of tamoxifen versus ovarian ablation for metastatic breast cancer in premenopausal women: A report of the National Cancer Institute of Canada Clinical Trials Group (NCIC CTG) trial MA.1

By Sawka C.A.  

Breast Cancer Research and Treatment, Vol. 44, Iss. 3, 1997-07 ,pp. : 211-215

Springer Publishing Company

Access to resources Recommend Favorite

Quality of Life Analyses in a Clinical Trial of DPPE (tesmilifene) Plus Doxorubicin Versus Doxorubicin in Patients with Advanced or Metastatic Breast Cancer: NCIC CTG Trial MA.19

By Liu Jianhua   Tu Dongsheng   Dancey Janet   Reyno Leonard   Pritchard Kathleen I.   Pater Joseph   Seymour Lesley K  

Breast Cancer Research and Treatment, Vol. 100, Iss. 3, 2006-12 ,pp. : 263-271

Springer Publishing Company

Access to resources Recommend Favorite

A Southwest Oncology Group Randomized Phase II Study of Doxorubicin and Paclitaxel as Frontline Chemotherapy for Women with Metastatic Breast Cancer

By Lyman Gary   Green Stephanie   Ravdin Peter   Geyer Charles   Russell Christy   Balcerzak Stanley   Thomas Budd G.   Martino Silvana  

Breast Cancer Research and Treatment, Vol. 85, Iss. 2, 2004-05 ,pp. : 143-150

Springer Publishing Company

Access to resources Recommend Favorite